SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Seattle Genetics (SGEN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (31)3/10/2004 5:08:41 AM
From: Icebrg   of 161
 
>>Why is this published under the auspices of Fred Hutchinson? Does SGEN have a deal with them?>>

There seems at least to exist a relatively strong personal link between Fred Hutchinson and SGEN. One of the directors has a background that is intertwined with FH and BMS (SGEN is a spin-off from the latter).

Karl Erik Hellström, M.D., Ph.D., has served as a Director of Seattle Genetics since April 1998. Dr. Hellström joined the Pacific Northwest Research Institute in October 1997. Prior to that, he was with Bristol-Myers Squibb (initially Oncogen) since 1983. Dr. Hellström served within the BMS Pharmaceutical Research Institute as Vice President of Oncology Drug Discovery and Vice President of Immunotherapeutics. In 1975, he became Director of the Tumor Immunology Program at the Fred Hutchinson Cancer Research Center after serving as Professor of Pathology at the University of Washington Medical School starting in 1966. Dr. Hellström received his M.D. and Ph.D. degrees in tumor biology/immunogenetics from the Karolinska Institute in Stockholm, Sweden and has published over 450 scientific papers. Dr. Hellström has received many scientific awards, including the Yearly Award from the American Cancer Society, the Parke Davis Award in Experimental Pathology and the Humbold Award. In addition to Seattle Genetics, he serves as a director of GeneMax, a biotechnology company, and is a member of the Scientific Advisory Council Cancer Research Institute.

For a background on the spin-off you may turn to signalsmag.com

Erik
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News